January 2023

Linnaeus Therapeutics Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Cutaneous Melanoma

By |2023-01-25T00:56:39+00:00January 25th, 2023|

Linnaeus Therapeutics Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Cutaneous Melanoma Haddonfield NJ, January 19, 2023--Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small-molecule oncology therapeutics, today announced that the U.S. [...]

Read More

September 2022

Linnaeus Therapeutics Announces Issuance of Patent for LNS8801 by the U.S. Patent and Trademark Office

By |2022-09-27T18:05:10+00:00September 27th, 2022|

Linnaeus Therapeutics Announces Issuance of Patent for LNS8801 by the U.S. Patent and Trademark Office Haddonfield NJ, September 21, 2022 - Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that [...]

Read More

Linnaeus Therapeutics Announces Presentation of LNS8801 Clinical Data at 2022 ESMO Annual Meeting

By |2022-09-27T18:00:44+00:00September 27th, 2022|

Linnaeus Therapeutics Announces Presentation of LNS8801 Clinical Data at 2022 ESMO Annual Meeting Haddonfield NJ, September 12, 2022 - Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small-molecule oncology therapeutics, today announced the presentation of clinical biomarker [...]

Read More

June 2022

Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 at 2022 ASCO Annual Meeting

By |2022-06-09T18:57:27+00:00June 9th, 2022|

Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 at 2022 ASCO Annual Meeting Haddonfield NJ, June 6, 2022 -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small-molecule oncology therapeutics, today announced the presentation [...]

Read More

April 2022

Linnaeus Therapeutics Awarded $4,000,000 SBIR Phase 2 Bridge Award by the National Cancer Institute to Advance LNS8801 for the Treatment of Cutaneous and Uveal Melanoma

By |2022-04-11T14:39:13+00:00April 11th, 2022|

Linnaeus Therapeutics Awarded $4,000,000 SBIR Phase 2 Bridge Award by the National Cancer Institute to Advance LNS8801 for the Treatment of Cutaneous and Uveal Melanoma Haddonfield NJ, April 6, 2022 -- Linnaeus Therapeutics, Inc. (“Linnaeus”), a privately held biopharmaceutical company focused on the development and commercialization [...]

Read More

June 2017

Reduced medicine side effects

By |2017-06-30T02:09:05+00:00June 30th, 2017|

Reduced side effects of medicine Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

Read More

The flu virus stops spreading

By |2017-06-30T01:05:15+00:00June 30th, 2017|

Why the flu virus don't spread as you might expect Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices [...]

Read More

Consistent testing cannot fail

By |2017-06-29T19:09:47+00:00June 29th, 2017|

Consistent testing cannot fail Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

Read More

Alternative science benefits

By |2017-06-29T19:08:39+00:00June 29th, 2017|

Alternative science and the benefits Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

Read More

Modern medicine in space

By |2017-06-29T15:01:28+00:00June 29th, 2017|

What has modern medicine learnt from humans in space? Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla [...]

Read More
© Copyright 2012 -    |   ALL RIGHTS RESERVED